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Comment on ‘No major role for glutathione
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sensitization to para-phenylenediamine and
other xenobiotics: a study of association and
a meta-analysis’
DOI: 10.1111/j.1365-2133.2011.10405.x
MADAM, The correspondence of Pot and colleagues ‘No major
role for glutathione S-transferase gene polymorphisms in sen-
sitization to para-phenylenediamine and other xenobiotics: a
study of association and a meta-analysis’1 may leave the
impression that we had argued that glutathione S-transferase
(GST) polymorphisms may be generally associated with con-
tact allergy.2 In fact, we investigated GST polymorphisms in
sensitization to mercury-containing compounds such as thio-
mersal (thimerosal), as thiomersal is exclusively detoxified via
glutathione conjugation. We therefore compared thiomersal-
sensitized individuals with healthy controls and individuals
who were sensitized toward para-phenylenediamine. We found
that GSTM1 confers a protective effect towards thiomersal and
an additive effect concerning GSTT1. We observed no associa-
tion in the case of para-phenylenediamine sensitization. The
latter is consistent with the notion that the compound is not
predominantly detoxified via the GST conjugation. We con-
cluded that ‘Patients sensitized to thiomersal exhibited
GSTM1-negative genotypes significantly more frequently than
the control group. This seems to reveal a substance-specific
association and not a general trait of contact allergic patients,
as the more frequent occurrence of the GSTM1 deficiency was
not seen in contact allergic patients sensitized against
para-substituted-aryl compounds. Furthermore the GST allele
frequencies in the ‘‘thiomersal-group’’ are not influenced by
additional allergies other than phenylmercury or ammoniated
mercury chloride. This further supports the concept that the
investigation of enzyme polymorphisms may yield allergen-
specific genetic markers for increased risk.’ We interpret this
substance-specific finding as indirect affirmation of the hapten
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Comment on ‘No major role for glutathione
S-transferase gene polymorphisms in
sensitization to para-phenylenediamine and
other xenobiotics: a study of association
and a meta-analysis’: reply from authors
DOI: 10.1111/j.1365-2133.2011.10406.x
MADAM, We would like to thank Westphal and Schnuch for
responding to our letter, ‘No major role for glutathione
S-transferase gene polymorphisms in sensitization to para-
phenylenediamine and other xenobiotics: a study of associa-
tion and a meta-analysis’.1
As described in their paper, we have acknowledged the fact
that Westphal et al.2 referred to the substrate specificity of thio-
mersal (thimerosal) for glutathione S-transferase (GST)
enzymes. However, both papers used in our meta-analysis also
describe the possible role of oxidative stress in sensitization to
the studied xenobiotics. Wang et al.3 suggested that poor GSTT1
activity reduced the protection from reactive oxygen species
(ROS) damage and therefore contributed to the occurrence of
allergic contact dermatitis to chromate. In addition, Westphal
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et al.2 mentioned the lack of complete understanding of thio-
mersal allergy and discussed the possibility that the toxicity of
thiomersal could have been indirectly related to – among other
things – oxidative stress. Moreover, a recently published paper
addressed the induction of ROS and CD86 by thiomersal- and
mercury analogue-treated monocyte-derived dendritic cells.4 In
general, reduced protection against and subsequent exposure to
ROS has been related to contact dermatitis. With the linkage of
metabolism of the particular allergens to ROS, and the general
linkage of ROS to contact sensitization,5 we believe that the
performed meta-analysis is defensible and justifiable.
Nevertheless, as mentioned in our paper, the differences
found in the meta-analysis can be partially explained by the
fact that detoxification of the different xenobiotics is depen-
dent on additional factors and cannot be attributed solely to
the examined GST genes. This might, as addressed in Westphal
and Schnuch’s response,6 particularly be the case for para-
phenylenediamine. On the other hand, looking in closer detail
actually reveals that results from our study are not that differ-
ent from those of Westphal et al.2 They did not find a signifi-
cant association of the GSTT1 deletion polymorphism with
sensitization and only found a relatively moderate odds ratio
for GSTM1 deficiency (odds ratio 2Æ0, 95% confidence interval
1Æ2–3Æ4, n = 60 cases), while studying the GST model sub-
strate thiomersal. This suggests that for substrates presumably
solely metabolized by GSTs, the effect of GST polymorphisms
on sensitization is small. From a substrate specificity perspec-
tive, one would then expect that xenobiotics which are not a
model substrate and are not solely detoxified by GSTs have an
even lower, or no association, as was shown in our study.
Hence, we still support our conclusion that common genetic
polymorphisms in GSTs seem not to play a major role in pre-
disposition to sensitization.
L .M. POT
B .Z . AL I ZADEH*
D. AHRENBERG
P . - J . COENRAADS
H. SN I EDER*
B . BL O¨MEKE
Department of Dermatology, University Medical
Centre Groningen, University of Groningen,
Groningen, the Netherlands
*Unit of Genetic Epidemiology & Bioinformatics,
Department of Epidemiology, University Medical
Centre Groningen, University of Groningen,
Groningen, the Netherlands
Department of Environmental Toxicology,
University Trier,





1 Pot LM, Alizadeh BZ, Ahrenberg D et al. No major role for glutathione
S-transferase gene polymorphisms in sensitization to para-phenylene-
diamine and other xenobiotics: a study of association and a meta-anal-
ysis. Br J Dermatol 2011; 164:890–1.
2 Westphal GA, Schnuch A, Schulz TG et al. Homozygous gene dele-
tions of the glutathione S-transferases M1 and T1 are associated
with thimerosal sensitization. Int Arch Occup Environ Health 2000;
73:384–8.
3 Wang BJ, Shiao JS, Chen CJ et al. Tumour necrotizing factor-alpha
promoter and GST-T1 genotype predict skin allergy to chromate in
cement workers in Taiwan. Contact Dermatitis 2007; 57:309–15.
4 Migdal C, Tailhardat M, Courtellemont P et al. Responsiveness of
human monocyte-derived dendritic cells to thimerosal and mercury
derivatives. Toxicol Appl Pharmacol 2010; 246:66–73.
5 Vandebriel RJ, Pennings JLA, Baken KA et al. Keratinocyte gene
expression profiles discriminate sensitizing and irritating compounds.
Toxicol Sci 2010; 117:81–9.
6 Westphal GA, Schnuch A. Comment on ‘No major role for glu-
tathione S-transferase gene polymorphisms in sensitization to para-
phenylenediamine and other xenobiotics: a study of association and
a meta-analysis’. Br J Dermatol 2011 [Epub ahead of print] DOI:
10.1111/j.1365-2133.2011.10405.x
Funding sources: L.M.P. was funded by the Department of Dermatol-
ogy of the University Medical Centre Groningen, the Netherlands.
Conflicts of interest: none declared.
Human papillomavirus types 1, 16 and 18
detected in a lesion of verrucous carcinoma of
the cheek
DOI: 10.1111/j.1365-2133.2011.10417.x
MADAM, Verrucous carcinoma (VC) is a distinctive form of
low-grade squamous cell carcinoma, first reported by Acker-
man in 1948.1 VCs are divided into four groups according to
the anatomical site: oral cavity (oral florid papillomatosis),
anogenital area (giant condyloma of Buschke and Lowenstein),
plantar area (epithelioma cuniculatum) and other cutaneous
sites.2,3 Human papillomavirus (HPV) infection is believed to
be a causative factor of VCs of the oral cavity, anogenital and
plantar area,2–6 but has never been detected on the cheek, a
very rare site of VC. We describe the first case of VC of the
cheek with detection of HPV types 1, 16 and 18.
In June 2009, a 79-year-old Korean woman presented with
a 2-year history of a pruritic, keratotic and verrucoid tumour
on the right cheek. She had been taking medication for dia-
betes and hypertension for 20 years. On physical examination,
an exophytic, verrucous and hyperkeratotic 3 · 2 cm round
tumour was observed on the right cheek (Fig. 1a). An initial
superficial punch biopsy of the lesion showed pseudoepitheli-
omatous hyperplasia with a dense inflammatory cell infiltrate
in the dermis. It was difficult to confirm the lesion as VC, so
we treated her with a wide excision and a transposition flap.
Histopathological findings of the excised specimen revealed
a well-circumscribed tumour that showed marked hyperkera-
tosis, papillomatosis, acanthosis of the epidermis and a down-
ward bulbous growth of elongated, blunted rete ridges.
Hyperplastic epidermis had invaded into the dermis, most
likely bulldozing, with keratinocytes that had a ground-glass
appearance (Fig. 1b, c). Keratinocyte atypia were few or
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